Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christian Spies , Ziyad M Hijazi Added: 3 years ago
Unlike the left-sided semi-lunar valve, clinically significant acquired pulmonary valve disease is rare. However, stenotic or regurgitant pulmonary valve lesions are not uncommon following surgery for congenital heart defects, including tetralogy of Fallot, pulmonary atresia and other surgical procedures requiring reconstruction of the right ventricular outflow tract (RVOT).1–4 Even with the use… View more
Author(s): Catalin Toma Added: 1 year ago
TCT 22 - Dr Catalin Toma (University of Pittsburgh Medical Center, Pittsburgh, PA, US) joins us to discuss the findings of the FLASH Study, a real-world registry with over 1300 participants. This trial aims to analyse the safety and effectiveness of Inari's FlowTriever System for the removal of emboli from the pulmonary arteries in patients with acute pulmonary embolism. Dr Toma presents the… View more
Author(s): Felix Mahfoud , Nils Kucher Added: 1 year ago
Pulmonary Embolism is a common disease with a challenging diagnosis. It is the third leading cause of cardiovascular mortality after heart attack and stroke. Despite high mortality rates, anticoagulation alone remains the mainstay treatment for nearly half of the patients diagnosed with PE. 20-50% of them have residual thrombus after receiving conservative treatment, developing life limiting… View more
Author(s): Nicolas Meneveau , Andrew SP Sharp , Adriaan Kraaijeveld Added: 5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data Satellite symposium at ESC Congress 2018 sponsored by EKOS Corporation Part 1: Prof Nicolas Meneveau - (Besancon, FR) Part 2: Prof Andrew Sharp - (Exeter, UK) Part 3: Prof Adriaan Kraaijeveld - (Utrecht, NL) View more
Author(s): Satinder K Sandhu Added: 3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed. Interatrial Septal Defect Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of… View more
Job title: Director, Interstitial Lung Disease Program
Personal History Dr Gary Matthew Hunninghake is a Pulmonologist and Genetic Epidemiologist based in Boston, MA. Academic History In 1999, Dr Hunninghake received his M.D. from the University of Iowa College of Medicine (now the Roy J. and Lucille A. Carver College of Medicine). He then completed a Residency in Internal Medicine and a Chief Residency (1999 - 2002) at the Medical… View more
Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Myung H Park, MD, FACC, is an Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. She is a member of the American College of Cardiology, the Heart Failure Society of America, the International Society of Heart and Lung Transplantation, and the Pulmonary Hypertension Association… View more